175 related articles for article (PubMed ID: 37072680)
1. Intracellular Expression of CTB in
Choi H; Son S; Lee D; Bae J; Seo E; Kim DW; Kim EJ
J Microbiol Biotechnol; 2023 Jun; 33(6):736-744. PubMed ID: 37072680
[TBL] [Abstract][Full Text] [Related]
2. Inactivated
Kim EJ; Bae J; Ju YJ; Ju DB; Lee D; Son S; Choi H; Ramamurthy T; Yun CH; Kim DW
J Microbiol Biotechnol; 2022 Nov; 32(11):1396-1405. PubMed ID: 36317425
[TBL] [Abstract][Full Text] [Related]
3. Novel Cholera Toxin Variant and ToxT Regulon in Environmental
Neogi SB; Chowdhury N; Awasthi SP; Asakura M; Okuno K; Mahmud ZH; Islam MS; Hinenoya A; Nair GB; Yamasaki S
Appl Environ Microbiol; 2019 Feb; 85(3):. PubMed ID: 30446560
[TBL] [Abstract][Full Text] [Related]
4. Construction of a Vibrio cholerae prototype vaccine strain O395-N1-E1 which accumulates cell-associated cholera toxin B subunit.
Rhie GE; Jung HM; Kim BS; Mekalanos JJ
Vaccine; 2008 Oct; 26(43):5443-8. PubMed ID: 18582519
[TBL] [Abstract][Full Text] [Related]
5. Expression of Cholera Toxin (CT) and the Toxin Co-Regulated Pilus (TCP) by Variants of ToxT in
Lee D; Choi H; Son S; Bae J; Joo J; Kim DW; Kim EJ
Toxins (Basel); 2023 Aug; 15(8):. PubMed ID: 37624264
[TBL] [Abstract][Full Text] [Related]
6. Investigation into immunological responses against a native recombinant CTB whole-cell Vibrio cholerae vaccine in a rabbit model.
Boustanshenas M; Bakhshi B; Ghorbani M
J Appl Microbiol; 2013 Feb; 114(2):509-15. PubMed ID: 23082752
[TBL] [Abstract][Full Text] [Related]
7. Expression of toxin co-regulated pilus subunit A (TCPA) of Vibrio cholerae and its immunogenic epitopes fused to cholera toxin B subunit in transgenic tomato (Solanum lycopersicum).
Sharma MK; Singh NK; Jani D; Sisodia R; Thungapathra M; Gautam JK; Meena LS; Singh Y; Ghosh A; Tyagi AK; Sharma AK
Plant Cell Rep; 2008 Feb; 27(2):307-18. PubMed ID: 17962948
[TBL] [Abstract][Full Text] [Related]
8. [An avirulent vibrio cholerae strain--producer of the cholera toxin B subunit: obtaining and molecular genetic analysis].
Smirnova NI; Krepostnova IM; Livanova LF; Zadnova SP; Eremin SA; Il'ina TS
Mol Gen Mikrobiol Virusol; 2007; (4):7-13. PubMed ID: 18154075
[TBL] [Abstract][Full Text] [Related]
9. Deciphering the possible role of ctxB7 allele on higher production of cholera toxin by Haitian variant Vibrio cholerae O1.
Naha A; Mandal RS; Samanta P; Saha RN; Shaw S; Ghosh A; Chatterjee NS; Dutta P; Okamoto K; Dutta S; Mukhopadhyay AK
PLoS Negl Trop Dis; 2020 Apr; 14(4):e0008128. PubMed ID: 32236098
[TBL] [Abstract][Full Text] [Related]
10. Construction and characterization of recombinant Vibrio cholerae strains producing inactive cholera toxin analogs.
Häse CC; Thai LS; Boesman-Finkelstein M; Mar VL; Burnette WN; Kaslow HR; Stevens LA; Moss J; Finkelstein RA
Infect Immun; 1994 Aug; 62(8):3051-7. PubMed ID: 8039872
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of a mutant B subunit in toxigenic Vibrio cholerae diminishes production of active cholera toxin in vivo.
Silva A; Fando R; Benitez JA
Curr Microbiol; 1998 Oct; 37(4):231-5. PubMed ID: 9732528
[TBL] [Abstract][Full Text] [Related]
12. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform.
Liao J; Gibson JA; Pickering BS; Watnick PI
mSphere; 2018 Jun; 3(3):. PubMed ID: 29875145
[TBL] [Abstract][Full Text] [Related]
13. Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein fused to the cholera toxin B subunit induces systemic and mucosal antiamebic and anti-V. cholerae antibody responses in mice.
Ryan ET; Butterton JR; Zhang T; Baker MA; Stanley SL; Calderwood SB
Infect Immun; 1997 Aug; 65(8):3118-25. PubMed ID: 9234763
[TBL] [Abstract][Full Text] [Related]
14. Bile acids induce cholera toxin expression in Vibrio cholerae in a ToxT-independent manner.
Hung DT; Mekalanos JJ
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):3028-33. PubMed ID: 15699331
[TBL] [Abstract][Full Text] [Related]
15. Effect of anaerobiosis on expression of virulence factors in Vibrio cholerae.
Krishnan HH; Ghosh A; Paul K; Chowdhury R
Infect Immun; 2004 Jul; 72(7):3961-7. PubMed ID: 15213140
[TBL] [Abstract][Full Text] [Related]
16. Construction and evaluation of a safe, live, oral Vibrio cholerae vaccine candidate, IEM108.
Liang W; Wang S; Yu F; Zhang L; Qi G; Liu Y; Gao S; Kan B
Infect Immun; 2003 Oct; 71(10):5498-504. PubMed ID: 14500467
[TBL] [Abstract][Full Text] [Related]
17. Vibrio pathogenicity island and cholera toxin genetic element-associated virulence genes and their expression in non-O1 non-O139 strains of Vibrio cholerae.
Sarkar A; Nandy RK; Nair GB; Ghose AC
Infect Immun; 2002 Aug; 70(8):4735-42. PubMed ID: 12117994
[TBL] [Abstract][Full Text] [Related]
18. Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development.
Sanchez J; Holmgren J
Proc Natl Acad Sci U S A; 1989 Jan; 86(2):481-5. PubMed ID: 2492108
[TBL] [Abstract][Full Text] [Related]
19. Immunogenic efficacy of DNA and protein-based vaccine from a chimeric gene consisting OmpW, TcpA and CtxB, of Vibrio cholerae.
Zareitaher T; Sadat Ahmadi T; Latif Mousavi Gargari S
Immunobiology; 2022 Mar; 227(2):152190. PubMed ID: 35220071
[TBL] [Abstract][Full Text] [Related]
20. Cholera toxin-B (ctxB) antigen expressing Salmonella Typhimurium polyvalent vaccine exerts protective immune response against Vibrio cholerae infection.
Vishwakarma V; Sahoo SS; Das S; Ray S; Hardt WD; Suar M
Vaccine; 2015 Apr; 33(15):1880-9. PubMed ID: 25701672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
